Avi Oler | Senior Vice President-Corporate Development and General Counsel |
Steve Fruchtman | President and Chief Executive Officer |
Mark Gelder | Chief Medical Officer |
Mark Guerin | Chief Financial Officer |
Charles Zhu | Guggenheim |
Ahu Demir | Ladenburg |
Joe Pantginis | H.C. Wainright |
Robert LeBoyer | Noble Capital Markets |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics' First Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared [Technical Difficulty] [Operator Instructions] As a reminder, this call is being recorded today, May 11,022. At this time, I'd like to turn the call over to Avi Oler, Senior Vice President of Corporate Development and General Counsel.